DSpace Repository

Prevalence of Psychiatric Symptoms Associated with Vitamin D Level in Long COVID: Preliminary Study

Show simple item record

dc.contributor.author Karn Matangkha en_US
dc.contributor.author Jarasphol Rintra en_US
dc.contributor.author Vichit Punyahotara en_US
dc.contributor.author Phakkharawat Sittiprapaporn en_US
dc.date.accessioned 2025-07-25T05:47:26Z
dc.date.available 2025-07-25T05:47:26Z
dc.date.issued 2025-07-25
dc.identifier.citation GMS Medicine Journal. Vol.5, No.3 (September - December 2025) : p.149-158 en_US
dc.identifier.issn 2730-3446
dc.identifier.uri http://mfuir.mfu.ac.th:80/xmlui/handle/123456789/992
dc.description บทความ (Article) en_US
dc.description.abstract Background: Long COVID is a condition where individuals continue to experience persistent symptoms after recovering from the initial COVID-19 infection. Vitamin D is one of the vital minerals for maintaining normal health conditions and may be associated with the psychiatric symptoms of long COVID. Objective: To examine the prevalence of psychiatric symptoms in long COVID-19 patients in association with vitamin D levels. Materials and Methods: This study employed a cross-sectional descriptive design, focusing on 170 patients who had previously contracted the COVID-19 virus at Foresta Clinic. The data collected included demographic data, vitamin D levels, and psychiatric symptoms in long COVID (anxiety, depression, and sleep disorders). Result: The study results indicated a female-to-male ratio of 1.1:1 among the patients, with a mean age of 45.87 ± 8.65 years. Additionally, 62.4% had received three doses of the COVID-19 vaccine. The median blood vitamin D level was 22.96 ng/mL (IQR 18.77, 31.7), with 41.2% of participants showing insufficiency, 30.6% showing deficiency, and 28.2% having sufficient levels. Overall, psychiatric symptoms were found in 30.0% of the patients, with anxiety occurring in 15.3%, depression in 7.1%, and sleep disorders in 21.2%. Participants with psychiatric symptoms had significantly lower blood vitamin D levels compared to those without symptoms (p < 0.05). The prevalence of psychiatric symptoms was highest among those with vitamin D deficiency (46.2%), followed by those with vitamin D insufficiency (25.7%), and it was lowest in the vitamin D sufficient group (18.8%). Conclusion: Maintaining and assessing vitamin D levels in long-term COVID patients may help prevent or reduce the severity of psychiatric symptoms. Further research is needed to evaluate the effectiveness of vitamin D supplementation in long COVID patients with low vitamin D levels, as well as to monitor and assess psychological tests continuously. en_US
dc.language.iso en en_US
dc.publisher School of Medicine, Mae Fah Luang University en_US
dc.subject Long COVID en_US
dc.subject COVID-19 en_US
dc.subject Psychiatric Symptoms en_US
dc.subject Vitamin D en_US
dc.title Prevalence of Psychiatric Symptoms Associated with Vitamin D Level in Long COVID: Preliminary Study en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account